Capstone Holding Corp. — Director's Dealing 2012

Oct 19, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2012-10-18

Reporting Person: HOLLIMAN JOHN M III (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-10-18	Common Stock	P	100000	$0.14	Acquired	432614	Direct
2012-10-19	Common Stock	P	50000	$0.14	Acquired	482614	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1658	Indirect
Common Stock	3000	Indirect